(Q31141440)

English

Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 June 2017

Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification (English)

1 reference

Europe PubMed Central

29 June 2017

author name string

Anna V Yemelyanova

1

1 reference

Europe PubMed Central

29 June 2017

Russell Vang

2

1 reference

Europe PubMed Central

29 June 2017

Kara Judson

3

1 reference

Europe PubMed Central

29 June 2017

Lee-Shu-Fune Wu

4

1 reference

Europe PubMed Central

29 June 2017

Brigitte M Ronnett

5

1 reference

Europe PubMed Central

29 June 2017

language of work or name

0 references

publication date

1 January 2008

1 reference

Europe PubMed Central

29 June 2017

The American Journal of Surgical Pathology

1 reference

Europe PubMed Central

29 June 2017

32

1 reference

Europe PubMed Central

29 June 2017

128-138

1 reference

Europe PubMed Central

29 June 2017

1

1 reference

Europe PubMed Central

29 June 2017

Serous carcinogenesis in the fallopian tube: a descriptive classification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Diverse tumorigenic pathways in ovarian serous carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Pathology of ovarian cancer precursors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

Early de novo ovarian carcinoma. A study of fourteen cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706134

25 November 2018

KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants

1 reference

https://pubmed.ncbi.nlm.nih.gov/18779727

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/PAS.0B013E318181A7CE

1 reference

Europe PubMed Central

29 June 2017

0 references

1 reference

Europe PubMed Central

29 June 2017

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31141440&oldid=1545310451"